Stock Analiz

22nd Century Group, Inc. XXII

Medicinal Chemicals and Botanical Products · data as of November 13, 2026

$0.77Market cap $424216
Open the interactive analysis →

22nd Century Group, Inc. (XXII) is a healthcare company listed in the US with a market value of about $424216. In the twelve months to June 30, 2026 it had revenue of $15M and net income of -$4M, a net margin of -27.0%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -9% a year, a 5-year average ROIC of -139%.

About 22nd Century Group

22nd Century Group is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $528991 in 2014 to $18M in 2025, growth of about 37.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 7816413% over three years (dilution for shareholders). It spends 4% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • Profit margin improving
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.0
P/B0.0
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-2063.6%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-27.9%
Revenue growth (5 yrs, per year)-8.9%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-156.2%
ROIC (5-yr avg.)-138.5%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$15M$18M$24M$32M$41M$31M$28M$26M$26M$17M$12M
Net income-$4M-$5M-$15M-$141M-$60M-$33M-$20M-$27M-$8M-$13M-$12M
Free cash flow-$9M-$8M-$14M-$60M-$55M-$24M-$16M-$15M———
EPS (diluted)$-169.28$-52.87$-45711.05$-39743007.82$-25386097.16$-17196766.03$-11464510.69$-17196766.03$-4913361.72$-10645617.07$-12283404.31
Net margin-27.0%-28.7%-62.2%-437.1%-147.7%-105.4%-70.1%-102.8%-30.1%-78.5%-94.3%
ROIC—-67.0%-89.0%-478.1%-25.9%-32.8%-33.8%-37.1%-32.8%-17.6%-46.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does 22nd Century Group pay a dividend?

Not currently.

Is 22nd Century Group a good stock to buy?

We do not give buy or sell advice. 22nd Century Group scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.